A Conversation With Peter Raven

A scene from the Missouri Botanical Garden The saying "if you want something done, give it to a busy person" fits Peter Raven like a glove. Director of the Missouri Botanical Garden since 1971, home secretary of the National Academy of Sciences, and author of textbooks in biology and botany, Raven hosted about 5,000 scientists from more than 100 countries as president of the XVI International Botanical Congress in St. Louis August 1-7. With Harvard University's Edward O. Wilson, Raven is biodi

Written byBarry Palevitz and Ricki Lewis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Raven presided at the congress' opening ceremonies, fielded questions from reporters, and delivered a lecture predicting that two-thirds of the world's species may be gone by the middle of the next century, thanks largely to destruction of tropical ecosystems. In between he helped break ground for St. Louis' new Donald Danforth Plant Science Center. Scheduled to open in 2001 and energized by a collaboration among the Missouri Botanical Garden, state and local government, Monsanto Corp., the Danforth Foundation, and area universities, the center will explore research fronts in agriculture, plant biotechnology, and molecular biology.

At the congress Raven also took time to talk to The Scientist's Barry Palevitz and Ricki Lewis. Following, in question-and-answer format, is a summary of that conversation.

Q: The word biodiversity is as familiar to most people as ecology. How did that happen?

A: Ecology used to be the study of plant distribution around the world; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies